Does Aetna Cover Weight Loss Treatment in California? A 2026 Guide

Last updated: August 29, 2026

Aetna members in California often ask whether a weight-loss visit, nutrition counseling, or a GLP-1 such as Wegovy or Zepbound can run through a commercial plan, including telehealth. Coverage may apply for some medical visits. Pharmacy benefits are a separate question. Aetna typically uses CVS Caremark as PBM. Obesity drugs are often excluded, limited, or gated by BMI, comorbidity, and prior authorization rules. This 2026 guide explains how MHPAEA and SB 855 do not force GLP-1 coverage, Insurance Code § 10123.85 telehealth rules, the Caremark Zepbound timeline, Medicare GLP-1 Bridge (a different program), and how to verify benefits before you book.

See if you may qualify for online weight loss care with Klarity’s network of 2,000+ licensed providers. You can also browse conditions we treat.

Quick answer for 2026

Many fully insured Aetna commercial members in California can use in-network telehealth for a medically necessary evaluation when the visit is a covered medical service. That is not the same as a promise that Wegovy, Zepbound, phentermine, Contrave, or orlistat will be on your 2026 Caremark list. Coverage varies by employer group, HMO vs PPO, and whether obesity treatment is in the medical or pharmacy booklet. Always verify benefits before you book.

Do not confuse Aetna with Anthem Blue Cross or Blue Shield of California. Those are different carriers. CalPERS, Covered California, self-funded ERISA, Medi-Cal, and Medicare Advantage follow different rule sets than a standard Aetna PPO or HMO booklet.

Rules that apply (and ones that do not)

• Federal MHPAEA requires many group health plans and issuers to treat mental health benefits no more restrictively than medical/surgical benefits in the same classification. Obesity pharmacotherapy is generally a medical/pharmacy benefit, not an SB 855 mental health mandate.
• California SB 855 (Health & Safety Code § 1374.72 / Insurance Code § 10144.5) generally requires state-regulated commercial plans to cover medically necessary treatment of mental health and substance use disorders using generally accepted standards of care. It does not require Aetna or Caremark to cover a specific GLP-1 for weight management. ([Bloomberg Law](https://news.bloomberglaw.com/health-law-and-business/california-strengthens-mental-health-parity-law))
• Insurance Code § 10123.85 generally requires many California insurers to cover telehealth services on the same basis as in-person care when the service is otherwise covered. Plan network, credentialing, and medical necessity still apply. ([CCHP](https://www.cchpca.org/?policy=requirements-14); [FindLaw § 10123.85](https://codes.findlaw.com/ca/insurance-code/ins-sect-10123-85/))
• HHS and DEA extended COVID-era telemedicine flexibilities for prescribing many controlled medications through December 31, 2026 ([DEA](https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care); [Federal Register](https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled)). Phentermine and Qsymia are Schedule IV. GLP-1s, Contrave, and orlistat are not scheduled in the same way, so EPCS rules that apply to phentermine typically do not apply to those drugs. Flexibilities do not override Aetna PA.
• California Department of Insurance consumer hotline: 1-800-927-4357 ([CDI](https://www.insurance.ca.gov/01-consumers/101-help/)). Knox-Keene HMOs often go to DMHC instead of CDI. Medicare Advantage uses CMS organization determinations, not CDI as the primary forum. Medi-Cal and dual-eligible members follow Medi-Cal rules, not this commercial summary.

How CVS Caremark usually treats weight-loss drugs in 2026

Check your 2026 Aetna/Caremark formulary and pharmacy EOC. Plans often:

• Exclude anti-obesity drugs entirely on some commercial lists, or place them on a restricted rider
• Require PA with BMI thresholds, documented lifestyle attempts, and comorbidity notes when a GLP-1 is covered
• Treat Wegovy, Zepbound, and similar products as pharmacy benefits, not as office-visit benefits

CVS Caremark removed Zepbound from many commercial formularies effective July 1, 2025. Caremark stated it will add Zepbound back to commercial formularies as an additional preferred option on October 1, 2026 ([CVS Health](https://www.cvshealth.com/news/company-news/cvs-caremark-delivers-affordability-and-access-to-glp-1-weight-management-medications-with-expanded-coverage-options.html); [Reuters](https://www.reuters.com/legal/litigation/cvs-brings-back-coverage-lillys-obesity-drug-zepbound-2026-05-28/)). That is a PBM commercial-list change. Your Aetna group may still exclude obesity drugs, require step therapy, or keep PA after October 1. Wegovy, Foundayo, phentermine, Contrave, and orlistat follow their own tier and PA rules. Klarity clinicians can help you understand what a PA packet often includes. They cannot promise Aetna or Caremark will approve a drug.

Medicare GLP-1 Bridge is a different program

If you have Medicare (including many Medicare Advantage plans), do not assume your Aetna commercial Caremark list applies. CMS launched the Medicare GLP-1 Bridge beginning July 1, 2026. Eligible beneficiaries may access certain GLP-1s, including Wegovy, Zepbound, and Foundayo, at $50 per month through the CMS program, which is separate from a typical commercial Caremark formulary ([CMS](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge); [Medicare.gov](https://www.medicare.gov/coverage/weight-loss-drugs)). Eligibility, duration, and pharmacy channels follow CMS rules. Medi-Cal and dual-eligible members follow Medi-Cal, not this commercial Aetna summary.

What a Klarity visit in California typically includes

Licensed providers in Klarity’s 2,000+ network can take history, review BMI and related conditions, and discuss whether a prescription, referral, or lifestyle plan is appropriate. Care is telehealth when clinically suitable. If a medication is prescribed, your Aetna/Caremark plan still decides coverage, copay, and pharmacy.

Verify whether online weight loss care may fit your situation.

Appeals

If Aetna denies a visit or PA, use the plan’s internal appeal first. Fully insured California commercial members may then use CDI or DMHC independent medical review, depending on product type. Self-funded ERISA plans generally use the employer’s federal appeal path. Medicare Advantage uses organization determinations, then Maximus IRE. Medi-Cal uses state fair hearing paths.

Related California guides

• Aetna ADHD treatment in California
• Aetna anxiety treatment in California
• Aetna depression treatment in California
• Blue Shield weight loss treatment in California

Disclaimer

This article is educational, not a benefits determination. Coverage varies by plan, formulary year, and medical necessity. Confirm benefits with Aetna and CVS Caremark before you start care. If you are in crisis, call or text 988.

Check if your plan may cover this kind of visit · See conditions